Skip to main content

Day: January 21, 2022

Heartland Media Acquisition Corp. Announces Pricing of $175 Million Initial Public Offering

Written by Customer Service on . Posted in Public Companies.

ATLANTA, Jan. 20, 2022 (GLOBE NEWSWIRE) — Heartland Media Acquisition Corp. (the “Company”) today announced the pricing of its initial public offering of 17,500,000 units, at a price of $10.00 per unit. The units will be listed on the New York Stock Exchange (“NYSE”) and trade under the ticker symbol “HMA.U” beginning on January 21, 2022. Each unit consists of one share of Class A common stock and one-half of one redeemable warrant, with each whole warrant exercisable to purchase one share of Class A common stock at a price of $11.50 per share. Only whole warrants will be exercisable. Once the securities comprising the units begin separate trading, the shares of Class A common stock and warrants are expected to be listed on the NYSE under the symbols “HMA” and “HMA.WS,” respectively. The offering is expected to close on January...

Continue reading

Clover’s Final SPECTRA Phase 2/3 Clinical Trial Efficacy Data Is Published in The Lancet

Written by Customer Service on . Posted in Public Companies.

CHENGDU, China, Jan. 21, 2022 (GLOBE NEWSWIRE) — Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, today announced that final efficacy data from SPECTRA, a global Phase 2/3 clinical trial evaluating the efficacy, safety, and immunogenicity of its COVID-19 vaccine candidate, SCB-2019 (CpG 1018/Alum), has been published in the peer-reviewed journal, The Lancet. The paper, ‘Efficacy of the adjuvanted subunit protein Covid-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial,’ may be accessed here. SCB-2019 (CpG 1018/Alum) achieved the primary efficacy endpoint and secondary efficacy endpoints. The COVID-19 vaccine candidate also demonstrated 100% efficacy against severe...

Continue reading

Sintana Announces Amendment to Proposed Acquisition of Petroleum Exploration License Interests in Namibia

Written by Customer Service on . Posted in Mergers And Acquisitions.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, Jan. 20, 2022 (GLOBE NEWSWIRE) — Sintana Energy Inc. (TSXV: SEI) (the “Company” or “Sintana”) announces today that it has entered into an amendment agreement dated January 20, 2022 (the “Amendment Agreement”) with respect to its previously announced proposed acquisition (the “Acquisition”) of a 49% interest in all of the issued and outstanding shares of Inter Oil (Pty) Ltd. (“Inter Oil”) from Grisham Assets Corp. (“Grisham”). As previously announced, Inter Oil indirectly holds a strategic portfolio of onshore and offshore petroleum exploration license interests in Namibia. The consideration for the Acquisition consists of an aggregate of 34,933,333 common shares of the Company and a cash payment in the amount of US$4,000,000...

Continue reading

Pretivm Announces Shareholder Approval of Plan of Arrangement at Special Meeting and Provides Transaction Update

Written by Customer Service on . Posted in Mergers And Acquisitions.

VANCOUVER, British Columbia, Jan. 20, 2022 (GLOBE NEWSWIRE) — Pretium Resources Inc. (TSX/NYSE: PVG) (“Pretivm” or the “Company”) today announced that the Company’s Securityholders (as defined below) approved the previously announced acquisition of Pretivm by Newcrest Mining Limited (ASX/TSX/PNGX: NCM) (“Newcrest”) by way of a plan of arrangement (the “Transaction”) at a special meeting of Securityholders held earlier today (the “Meeting”). The special resolution approving the Transaction was approved by 95.48% of the votes cast by Pretivm’s shareholders and holders of options to acquire shares of the Company (collectively, the “Securityholders”), present virtually or represented by proxy at the Meeting, voting together as a single class. Transaction Details Under the terms of the Transaction, Pretivm shareholders were able to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.